More than a decade ago, when most people were still using not-so-smart mobile phones, the first human genome was sequenced. It cost $3 billion. In the time it took for smartphones to become the essential consumer technology, DNA sequencing rapidly evolved from a costly, uncommonly used process into a quick, reliable, relatively cheap and widely used predictive tool to give insight on disease risk...
The NIH's Precision Medicine Initiative has selected Eric Dishman, former director of health innovation and policy at Intel, to serve as director of the PMI's Cohort Program.
"Eric will lead NIH’s effort to build the PMI landmark longitudinal research study of one million or more U.S. volunteers to expand our ability to improve health and treat disease through precision medicine," NIH Director...
This summer, National Institutes of Health (NIH) will launch a Participant Technologies Center to test and maintain connected sensor technologies as part of the White House’s Precision Medicine Initiative (PMI), NIH Director Francis Collins announced today at the Precision Medicine Summit. Vanderbilt University, with help from Verily (formerly known as Google Live Sciences) as advisors, will...
Fitbit Surge
It looks like the NIH may be the next big stakeholder to look to mobile tools for data collection in clinical research, joining the likes of Apple and Google. As part of the White House's Precision Medicine Initiative (PMI), announced in January during the State of the Union address, the NIH is considering using smartphones and wearables for data collection, according to a new...
